Snowden Capital Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $17.8M | Buy |
50,498
+4,433
| +10% | +$1.58M | 0.47% | 33 |
|
|
2025
Q4 | $15.1M | Buy |
46,065
+4,663
| +11% | +$1.48M | 0.39% | 44 |
|
|
2025
Q3 | $11.7M | Sell |
41,402
-1,068
| -3% | -$310K | 0.32% | 57 |
|
|
2025
Q2 | $11.9M | Buy |
42,470
+2,158
| +5% | +$611K | 0.35% | 54 |
|
|
2025
Q1 | $12.6M | Buy |
40,312
+9,727
| +32% | +$2.87M | 0.4% | 46 |
|
|
2024
Q4 | $7.97M | Sell |
30,585
-8,086
| -21% | -$2.4M | 0.25% | 79 |
|
|
2024
Q3 | $12.5M | Sell |
38,671
-614
| -2% | -$201K | 0.37% | 48 |
|
|
2024
Q2 | $12.3M | Buy |
39,285
+22,364
| +132% | +$6.57M | 0.36% | 50 |
|
|
2024
Q1 | $4.81M | Buy |
16,921
+6,114
| +57% | +$1.79M | 0.15% | 185 |
|
|
2023
Q4 | $3.11M | Buy |
10,807
+355
| +3% | +$96.7K | 0.12% | 220 |
|
|
2023
Q3 | $2.81M | Sell |
10,452
-2,106
| -17% | -$526K | 0.12% | 229 |
|
|
2023
Q2 | $2.79M | Buy |
12,558
+2,617
| +26% | +$607K | 0.1% | 241 |
|
|
2023
Q1 | $2.4M | Buy |
9,941
+3,139
| +46% | +$771K | 0.09% | 255 |
|
|
2022
Q4 | $1.79M | Sell |
6,802
-549
| -7% | -$147K | 0.07% | 303 |
|
|
2022
Q3 | $1.66M | Buy |
7,351
+200
| +3% | +$48.5K | 0.07% | 298 |
|
|
2022
Q2 | $1.74M | Buy |
7,151
+688
| +11% | +$169K | 0.08% | 284 |
|
|
2022
Q1 | $1.56M | Buy |
6,463
+3,680
| +132% | +$846K | 0.06% | 319 |
|
|
2021
Q4 | $626K | Sell |
2,783
-1,881
| -40% | -$397K | 0.03% | 412 |
|
|
2021
Q3 | $992K | Buy |
4,664
+233
| +5% | +$53.6K | 0.05% | 374 |
|
|
2021
Q2 | $1.08M | Sell |
4,431
-1,501
| -25% | -$369K | 0.05% | 354 |
|
|
2021
Q1 | $1.48M | Buy |
5,932
+908
| +18% | +$217K | 0.08% | 278 |
|
|
2020
Q4 | $1.16M | Buy |
5,024
+2,220
| +79% | +$512K | 0.08% | 287 |
|
|
2020
Q3 | $713K | Buy |
2,804
+38
| +1% | +$9.41K | 0.06% | 316 |
|
|
2020
Q2 | $652K | Sell |
2,766
-603
| -18% | -$138K | 0.06% | 322 |
|
|
2020
Q1 | $683K | Sell |
3,369
-34
| -1% | -$7.43K | 0.07% | 291 |
|
|
2019
Q4 | $820K | Buy |
3,403
+126
| +4% | +$27.8K | 0.07% | 304 |
|
|
2019
Q3 | $634K | Sell |
3,277
-531
| -14% | -$102K | 0.06% | 312 |
|
|
2019
Q2 | $702K | Sell |
3,808
-151
| -4% | -$27K | 0.07% | 291 |
|
|
2019
Q1 | $752K | Sell |
3,959
-29
| -0.7% | -$5.54K | 0.08% | 285 |
|
|
2018
Q4 | $776K | Sell |
3,988
-1,129
| -22% | -$220K | 0.1% | 258 |
|
|
2018
Q3 | $1.06M | Buy |
5,117
+739
| +17% | +$146K | 0.12% | 231 |
|
|
2018
Q2 | $808K | Sell |
4,378
-156
| -3% | -$27.6K | 0.1% | 253 |
|
|
2018
Q1 | $773K | Sell |
4,534
-6,233
| -58% | -$1.14M | 0.11% | 224 |
|
|
2017
Q4 | $1.87M | Buy |
10,767
+1,486
| +16% | +$263K | 0.27% | 122 |
|
|
2017
Q3 | $1.73M | Buy |
9,281
+957
| +11% | +$170K | 0.28% | 114 |
|
|
2017
Q2 | $1.43M | Buy |
8,324
+985
| +13% | +$160K | 0.27% | 127 |
|
|
2017
Q1 | $1.2M | Buy |
7,339
+750
| +11% | +$125K | 0.26% | 131 |
|
|
2016
Q4 | $963K | Buy |
+6,589
| New | +$992K | 0.24% | 143 |
|
Other funds holding AMGN
VCM
VPM
Snowden Capital Advisors's AMGN Position: Q1 2026 in Review
Snowden Capital Advisors increased its Amgen (AMGN) stake by 9.6% in Q1 2026, buying an estimated $1.58M and bringing the position to 50,498 shares worth $17.8M. The position accounts for 0.47% of the portfolio, ranked #33.
Snowden Capital Advisors first reported a position in AMGN in Q4 2016 and has held it in 38 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Snowden Capital Advisors held 50,498 shares of Amgen worth $17.8M as of Q1 2026.
- Snowden Capital Advisors bought 4,433 Amgen shares in Q1 2026, an estimated $1.58M.
- Amgen made up 0.47% of Snowden Capital Advisors's portfolio in Q1 2026, its #33 holding.
- Snowden Capital Advisors first reported a position in Amgen in Q4 2016 and has held it in 38 quarters since.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Snowden Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.